Myocarditis Registry for Children and Adolescents – MYKKE

Overview

MYKKE is a prospective multi-center registry for children and adolescents with myocarditis. The aim is to generate prospective multi-center data on epidemiology, diagnostics, and therapy of pediatric patients with myocarditis in order to enable evidence-based diagnostic and therapeutic approaches for this myocardial disease.

Full Title of Study: “Myocarditis Registry for Children and Adolescents – MYKKE”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 2024

Detailed Description

MYKKE is a long-term prospective registry providing a core platform for clinical research studies, which can be attached in a modular fashion. After a six-month pilot phase including 8 centers, the basic registry was opened in June 2014 to all hospitals in Germany treating patients with paediatric heart disease. While the scientific lead is with two study coordinators and a study group consisting of principal investigators from the collaborating centres ("MYKKE Investigators"), MYKKE is hosted and technically administered by the Competence Network for Congenital Heart Defects, which was initiated in 2003 by the Federal Ministry of Education and Research of the German government and is now part of the German Center for Cardiovascular Research (DZHK). Ethical approval was first obtained at the initiating centre (Deutsches Herzzentrum Berlin) and subsequently confirmed by local authorities of all collaborating centres. The treating physicians enter basic data from patients enrolled at the study site via an online web interface to a central study database. For each patient, a specific patient identification number (PID) is generated based on name, first name and date of birth in order to store data in a pseudonymized fashion. As the PIDs are generated by a specific algorithm, data from the same patient are always linked to the same dataset even when data from different visits are entered by different institutions. The web interface provides two different forms for each patient. The first form ("general sheet") is filled-in only at first presentation and consists of 12 items regarding disease and patient history, and initial symptoms of the disease. The second type of sheet ("current visit") can be generated once for each new patient visit and includes 52 items on characteristics of the current visit, current symptoms, diagnostic tests performed, confidence of the treating physician in the diagnosis on a subjective scale, left-ventricular function, therapy, complications, and follow-up care provider after discharge. Items primarily require yes/no responses via ticking respective boxes, allowing for completing each data sheet in <5 minutes when all data are available.

Clinical Trial Outcome Measures

Primary Measures

  • all cause mortality
    • Time Frame: one year
  • admission for heart failure
    • Time Frame: one year
  • major cardiovascular events
    • Time Frame: one year
    • cardiovascular death, need for mechanical ventricular support or heart transplantation, sustained ventricular arrhythmia, decompensated heart failure requiring catecholamine therapy

Secondary Measures

  • systolic dysfunction
    • Time Frame: one year
    • left ventricular ejection fraction <50%
  • diastolic dysfunction
    • Time Frame: one year
    • elevated natriuretic peptides, E/E’ >15, left ventricular ejection fraction >= 50%
  • impaired exercise tolerance
    • Time Frame: one year
    • maximal oxygen uptake (VO2max) <5th percentile of normal

Participating in This Clinical Trial

Inclusion Criteria

  • Admission or referral diagnosis of myocarditis – Age <18 years – Written informed consent of the parents or legal guardians Exclusion Criteria:

  • Unwillingness to give consent

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • German Heart Institute
  • Collaborator
    • Competence Network for Congenital Heart Defects
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Daniel R Messroghli, MD, Study Director, German Heart Institute
    • Stephan N Schubert, MD, Study Director, German Heart Institute
  • Overall Contact(s)
    • Thomas Pickardt, PhD, +49 30 4593, pickardt@kompetenznetz-ahf.de

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.